FDA staff on Friday flagged the risk of heart inflammation following the administration of the Novavax COVID-19 vaccine. In the company’s nearly 30,000 patient trial, conducted between December 2020 and September 2021, there were four cases of myocarditis detected within 20 days post-vaccination, the Epoch Times reports.
Related posts:
EVIDENCE: Covid Plandemic Was Being Schemed at Least as Far Back as 9/11
‘Now Is Go Time’: Stew Peters Is Threatening to Arrest Government Officials Over COVID Restrictions
Just How Many Shots are on the CDC Vaccine Schedule?
Palestinians receive 40,000 COVID-19 vaccines from UAE
We will kill 117 kids to save one child from dying from COVID in the 5 to 11 age range
Developer of COVID-19 Vaccine Passport Says 'Microchip implants are coming whether you like it or no...